— Emtholampilo wezifo zesikhumba othule, isiguli sibeka isilevu saso kudivayisi ebushelelezi. Izibani eziningi zikhanyisa ubuso baso, ziveza umonakalo welanga ongaphansi komhlaba kanye nemibimbi emincane engabonakali emehlweni. Lesi sigameko, esasike saba sezibhedlela zocwaningo ezisezingeni eliphezulu, sishesha singena emakhemisi, kumakhawunta obuhle, kanye nakuma-smartphone emhlabeni jikelele. Siqhutshwa yintuthuko ye-AI kanye nesidingo esikhulu sabathengi,abahlaziyi besikhumbabashintsha besuka kumagajethi okunethezeka baye ezintweni ezibalulekile zokunakekelwa kwempilo—kodwa indlela yabo igcwele izingxoxo zesayensi nezokuziphatha.
I. Inkinga Yokuba Nesidingo: Ngale “Kwesikhumba Esijulile”
Ukuxilongwa Kwezokwelapha Kuguqukile
Abahlaziyi besikhumba abangochwepheshe manje sebephikisana nokunemba kodokotela ekutholeni izimo ezisongela ukuphila. Izifundo zakamuva ziqinisekisa ukuthi ama-algorithms okufunda okujulile (DL) ahlukanisa ama-melanoma ngokuzwela okufika ku-94%, odokotela besikhumba abangochwepheshe abahambisana nezivivinyo ezilawulwayo. Ngokungafani namehlo abantu, la mathuluzi alinganisaukusatshalaliswa kombala, amaphethini emithambo yegazi, kanye nobuningi be-collagen kuzo zonke izendlalelo zesikhumba—okubalulekile ekulandeleleni izifo eziqhubekayo njenge-melanoma noma i-rosacea yokuvuvukala. Ipulatifomu yokuhlaziya isikhumba ezenzakalelayo yaseJalimane, isebenzisa isikhala sombala se-CIELAB kanye nama-algorithms e-OpenFace, ifinyelela ukunemba okungu-89-92% ezindaweni zezokwelapha, idlula kakhulu ukuthayipha kwe-Fitzpatrick okudala (≤20% ukunemba). Ukunemba okunjalo kwenza kube lula ukungenelela kusenesikhathi, kunciphisa ama-biopsy ahlaselayo.
Ukuthuthukiswa Kwempilo Yabathengi
Isidingo sokunakekelwa kwesikhumba okwenziwe ngokwezifiso sikhule kakhulu. Ngemva kobhubhane, amakhasimende obuhle angaphezu kuka-60% alindele ukubonisana nge-telehealth, lapho abahlaziyi be-AI bevala igebe lokukhetha ekuhlolweni okukude. Izinhlelo zokusebenza ezifana ne-Skinive zisebenzisa amakhamera e-smartphone ukuhlola ama-moles, ama-acne, kanye ne-eczema, zenza ukuhlolwa kwengozi okungaphezu kwezigidi ezintathu futhi zikhomba izifo ezingaba ngu-200,000. Imitholampilo ibika ukuthi amakhasimende athola ukuboniswa komonakalo we-UV okwenziwe yi-AI abonisa ukuthobela okuphezulu okungu-30% kwezindlela zokuvikela ilanga.
II. Ukuhlangana Kobuchwepheshe: Indlela i-AI Ebhala Kabusha Ngayo Imithetho
Kusukela Kumaphikseli Kuya Ekubikezelweni
Abahlaziyi besimanje bahlanganisa izithombe ze-multi-spectral (i-UV, i-polarized, i-RBG), bamaphe ama-biomarker esikhumba angu-14 ahlukene—kusukela ekuvuvukeni kwe-pore kuya ekuguqulweni kwe-pigmentation engaphansi kwesikhumba. Umngcele olandelayo uhilela ukufunda okuhlanganisiwe—ama-algorithms okuqeqesha kuwo wonke amadivayisi ahlukaniswe ngaphandle kokwabelana ngemininingwane yesiguli yangasese—kanye namanethiwekhi e-3D convolutional ahlaziya ukuvela kwe-lesion ngokuhamba kwesikhathi.
Ukuqhuma Kwemakethe Nokubusa Ngentando Yeningi
Imakethe yokuhlaziya isikhumba ye-AI izokhuphuka iye ku-$17.7 billion ngo-2032, iqhutshwa yi-medspas, izibhedlela, kanye nabasebenzisi basekhaya. "Amapeni okuhlola isikhumba" aphathekayo athengiswa ngaphansi kuka-$16 online, kuyilapho izinhlelo zezinga lomtholampilo zibusa emahhovisi e-dermatology. I-Asia-Pacific ihola ekuthathweni (isabelo semakethe esingu-40.2%), eqhutshwa abathengi abanolwazi ngobuchwepheshe kanye namazinga okukhula komdlavuza wesikhumba—amacala omhlaba wonke ayizigidi ezingu-1.5 atholakale ngo-2020 kuphela.
III. Inkinga Yokungabaza: Izikhala Zokunemba kanye Nomhlabathi Osheshayo Wokuziphatha
Uhlangothi Olumnyama Lokubusa Ngentando Yeningi
Amadivayisi abathengi abhekene nokuhlolwa okujulile. Izifundo zembula ukungalingani okwesabekayo: omunye umhlaziyi we-Amazon uphawule ukuthi ukufundwa kwezinga lomswakama kwahlukahluka kakhulu lapho kuhlolwa kabusha indawo efanayo.
Izindawo Ezimpunga Ezilawulwayo
I-FDA ikhiphe amadivayisi afana ne-DermaSensor ukuzeimisebenzi yezokwelapha, kodwa izinhlelo zokusebenza eziningi zabathengi zithatha indawo engalawulwa. Ukuthembela ngokweqile kuyingozi yokungatholakali kokuxilongwa: uhlelo lokusebenza olulodwa luhlukanise ngokungalungile isilonda esinonya ngokuthi “ingozi ephansi,” okubambezela i-biopsy ngezinyanga ezingu-8 (i-Journal of Clinical Dermatology, 2024). Ngenxa yalokho, ama-64% odokotela besikhumba bakhuthaza “ukuhlakanipha okukhulisiwe”—i-AI njengethuluzi, hhayi indawo—yokugcina ukuqapha kodokotela.
IV. Isinqumo: Esibalulekile, Kodwa Asisona Esingenaphutha
Abahlaziyi besikhumba bashintsha ngokungangabazeki i-dermatology. Kochwepheshe, bavumela ukulandelela ngokunembile i-melasma noma i-eczema; kubathengi, bayenza ingabonakali imfihlakaloukunakekelwa kwesikhumbaisayensi. Kodwa isidingo sazo sincike kumongo:
Izinhlelo Eziqinisekiswe Ngokwezokwelapha: Amathuluzi aqinisekiswe yi-FDA ezibhedlela anciphisa amaphutha okuxilonga kanye nokuhlolwa kwe-biopsy okungadingekile.
Isiqondiso Sabathengi: Izinhlelo zokusebenza zisebenza kahle kakhulu emfundweni nasekulandeleleni inqubekela phambili—hhayi ekuxilongweni.
Izithiyo Zokuziphatha: Idatha yokuqeqeshwa ehlukahlukene kanye nokusebenzisana kodokotela ne-AI akunakuxoxiswana ngakho.
Isikhathi sokuthunyelwe: Julayi-23-2025
